chrisvoncsefalvay/vaers-outcomes huggingface dataset:
had two shots, my daughter and I had it at the same time/ Suspected Vaccination failure; my daughter and I had it at the same time; Pain was unbelievable; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and pain were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: This case was reported by the patient's parent. The age at vaccination was not reported. The patient got both the Shingles shots and still got shingles. The reporter stated that the pain was unbelievable. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure since the details regarding time to onset and laboratory test confirming shingles were unknown at the time of reporting. This case had been linked with US2022AMR009082, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR009082:same reporter, other patient
received Tdap (Boostrix) vaccine instead of HepB vaccine; This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis.   On 01-SEP-2023, the patient received Boostrix. On 01-SEP-2023, an unknown time after receiving Boostrix, the patient experienced wrong vaccine administered (Verbatim: received Tdap (Boostrix) vaccine instead of HepB vaccine). The outcome of the wrong vaccine administered was unknown.  Additional Information: GSK Receipt Date: 05-SEP-2023 The reporter was an officer in charge of initial processing center, reported that a trainee (patient) received Tdap (Boostrix) vaccine instead of Hepatitis B vaccine, which led to wrong vaccine administered. The reporter did not had information about lot number, expiry date, patient initials, gender, date of birth, healthcare professional (HCP) contact information of the trainee, and mailing address of the camp she was calling from. The reporter stated that, she would need to contact her internal team to collect detailed information. This was 1 of the 112 cases, reported by the same reporter.; Sender's Comments:  US-GSK-US2023121025:Same reporter (1st Master case US2023121025 out of 112 cases)
It feels like I have covid again. My main symptom is inflammation or pleurisy around the lungs, but the tightness has gone up into my airway as of today. Arm is still very sore from shot 8 days later. Doctor put me on pain meds (hydrocodone and gave me a shot to help with inflammation)
Loss of vision, conjunctival chemosis, lightheadedness, shortness of breath and rales both lungs within 180 mins of influenza vaccination. Transferred to hospital, after epinephrine, BENADRYL, discharged after SOLU-MEDROL & PEPCID. Referred to ophthalmologist.
I had my vaccination on 09/07/2022. On 04/09/2023 I started to have problems with my throat and had to keep clearing it. The next morning I felt worse and I tested COVID-19 Negative. I started to have more cold like symptoms. On 04/12/2023 I tested COVID-19 Positive. I was prescribed Paxlovid. I still have a little bit of congestion but I feel fine on 04/27/2023.
Armpit pain; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY PAIN (Armpit pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced AXILLARY PAIN (Armpit pain). At the time of the report, AXILLARY PAIN (Armpit pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No laboratory data provided by reporter. No concomitant medication provided by reporter. No treatment medication provided by reporter.   Reporter did not allow further contact
SWEATY AFTER FEVER BROKE; FLU FEELING; MUSCLE SORENESS; CHILLS; FRONTAL HEADACHE; This spontaneous report received from a patient concerned a 50 year old female. The patient's weight was 173 pounds, and height was not reported. The patient's concurrent conditions included ehlers-danlos syndrome, sjogren's syndrome, and blood clotting disorder.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 203A21A, and batch number: 203A21A expiry: 23-JUN-2021) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 12-APR-2021, the subject experienced chills. On 12-APR-2021, the subject experienced frontal headache. On 13-APR-2021, the subject experienced sweaty after fever broke. On 13-APR-2021, the subject experienced flu feeling. On 13-APR-2021, the subject experienced muscle soreness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sweaty after fever broke, flu feeling, chills, frontal headache, and muscle soreness on 13-APR-2021. This report was non-serious.
Information has been received from a registered dietician concerning a male pt who at the age of 4 years old was vaccinated with a dose of MMRII (Lot # 644415/1008M).  Concomitant therapy included a dose of hepatitis B vaccine, recomb (manufacter unknown), IPV (unspecified) (manufacturer unknown) DTAP, Tetanus toxoid (manufacturer unknown).  In Feb 2003, the pt lost all hair.  The pt's mother noticed "a patch on the back of the boy's head the day after vaccination," and "within 2 weeks all hair was gone."  On 01/14/04, the pt's hair had not returned.  Unspecified medical attention was sought.  Upon internal review, alopecia was considered to be an other important medical event (OMIC).  Additional information has been requested. Follow up on 04/29/04 states: "In follow up information from the pt's mother, it was reported that the pt had allergies to soy and peanut products. She also reported that on 02/10/03 the pt received his second dose of hepatitis A virus vaccine inactivated (Lot # 643816/1061M) into the right thigh. A first dose of hepatitis A virus vaccine inactivated was given on 12/11/03.  It was reported that the pt was not ill at the time of vaccination. The reporter indicated that the pt received 4 shots in one day and about 2 weeks later, on 02/25/03, the pt had bad stomachaches and had to go to the MD for diarrhea.  Reportedly the pt woke up with a bald spot the size of a quarter and within 3 months he had no hair, eyebrows or eyelashes. The pt's mother noticed that a "different behavior", almost like she had a "different child".  She reported that the pt had memory loss on and off. The change in the pt's behavior was noticed by the mother, after vaccination with hepatitis A virus vaccine inactivated on 12/11/03 and the hair loss after vaccination with hepatitis A virus vaccine inactivated on 02/10/03.  According to the reporter, the physician diagnosed the pt with alopecia. Upon internal review, alopecia, memory impairment and abnormal behavior were considered to be an other important medical events.  The pt's experience were considered to be disabling by the pt's mother. Additional information has been requested."
Extreme fatigue a couple hours after receive, maybe around  2p. Took a nap for maybe 2 hours, face started to feel itchy and tight. Around 8pm I look in the mirror and I notice my face looked a little puffy, and tiny bumps around my nose and mouth.  The next morning, around 5am, my eyelids and lips were noticeable swollen and the hives (tiny bumps) were covering my face, it was itchy mostly around my nose and mouth. I took Zyrtec every day for three days. The swelling went down after the second day, the hives (tiny bumps) cleared up around day three, my skin  was completely normal after about a week. On April 13, I started to feel fatigued ( same way I did after I got the vaccine on the 3rd),  the next morning my eyelid and lips were swollen and hives and itchness returned. I contacted doctor and he suggested taking Allegra 24 during the day and Benadryl at night ) if I?m itchy. He almost prescribed prednisone for 3 days,but only take  if my face was still swelling the next day.  On the 14th, my face was still swelling so I started the prednisone. It took about 4 days for my face to clear up completely
arm sore; patient cannot work; redness; headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (arm sore), IMPAIRED WORK ABILITY (patient cannot work), ERYTHEMA (redness) and HEADACHE (headache) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0117A21A and 011A21A) for COVID-19 vaccination.     Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID] and ATORVASTATIN for an unknown indication.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Mar-2021, the patient experienced HEADACHE (headache). On an unknown date, the patient experienced PAIN IN EXTREMITY (arm sore), IMPAIRED WORK ABILITY (patient cannot work) and ERYTHEMA (redness). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (arm sore) and ERYTHEMA (redness) had resolved, IMPAIRED WORK ABILITY (patient cannot work) outcome was unknown and HEADACHE (headache) had not resolved.            Concomitant medication included prazole for blood pressure was noted.   It was noted that the patient went to the ER (emergency room) because they could not work. The ER advised that the patient take Tylenol for treatment.
Patient started feeling hot and had to lie down on the floor.  He then went to a HCF.
eye rolled back, drooping excessively & jerking all over; temp 101 w/APAP;
Headache initiated on day of injection remained dull for 36 hours then exacerbated to  migraine type headache with photophobia, Left occular area pain,  x 24 hours persisting at time of visit
This spontaneous report was received from a healthcare worker referring to a patient of unknown age and gender. The patient's pertinent medical history and drug reactions/allergies were not reported. On 08-JAN-2016, the patient was vaccinated with a dose of VAQTA (lot # L002717 and expiration date June 2017, unknown route of administration), which was exposed to temperatures outside of the recommended range. There were no concomitant medications provided. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Injection was given very high up near shoulder. Experiencing pain in left shoulder and unable to fully extend my arm. Was not able to sleep first 2 nights with pain. Still not able to lift arm without pain in shoulder.
Pt with fever 102 degrees post vaccine -> (B) otitis media -> AMOXIL 11 days post vaccination, pt with temp 100.1 previous OM but developed papular rash to chest -> neck -> cheeks -> trunk; spared extremities. Abx's d/c but rash progressed in few of the papular vesicles; no pustules. Rash resolved 5 days.
Spinal pain; This spontaneous case was reported by a consumer and describes the occurrence of SPINAL PAIN (Spinal pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SPINAL PAIN (Spinal pain). At the time of the report, SPINAL PAIN (Spinal pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  Treatment information was not provided.   Reporter did not allow further contact
Pt first experienced pain in right arm and down his right side. Pt reports waking up with fever, clamminess, and emesis x 6. Pt also reports photosensitivity on drive over.
20 mons. F with h/o complex febrile seizures x 4 in past who was admitted with generalized tonic - clonic seizure lasting longer than 30 mins., not breaking until DIASTAT and 5 doses of IV medication given. She had been febrile earlier in the evening to 101.4 then defervesced with TYLENOL, following which she went to sleep. She was not febrile (99.8 per mother) at time of seizure and acid timeline.
Complaint of bilateral hip and knee pain that lasted from 10/11/16 - 12/13/16.
2/3/03 - PT presents c/o rash to arms. D: left bicep, L : R shoulders with 2 cm x 0.5 cm raised red papule, back forearms with scattered papular pustules. A/P generalized pustulitis, no treatment.
Left armpit started bothering her after first dose; Weakness; Sweating; Stomach cramps; Her side effects made her nervous about the second shot; Left arm injection site was sore; Vomiting; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Left armpit started bothering her after first dose), ASTHENIA (Weakness), HYPERHIDROSIS (Sweating), ABDOMINAL PAIN UPPER (Stomach cramps) and NERVOUSNESS (Her side effects made her nervous about the second shot) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006D21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in December 2020.    On 25-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jul-2021, the patient experienced LIMB DISCOMFORT (Left armpit started bothering her after first dose), ASTHENIA (Weakness), HYPERHIDROSIS (Sweating), ABDOMINAL PAIN UPPER (Stomach cramps), NERVOUSNESS (Her side effects made her nervous about the second shot), VACCINATION SITE PAIN (Left arm injection site was sore), VOMITING (Vomiting) and NAUSEA (Nausea). At the time of the report, LIMB DISCOMFORT (Left armpit started bothering her after first dose), ASTHENIA (Weakness), HYPERHIDROSIS (Sweating), ABDOMINAL PAIN UPPER (Stomach cramps), NERVOUSNESS (Her side effects made her nervous about the second shot), VACCINATION SITE PAIN (Left arm injection site was sore), VOMITING (Vomiting) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  Treatment information was not provided.  The patient thought that may be she was having severe side effects because she already had antibodies.
1 week later on 16Mar2021, she was diagnosed with COVID; This is a spontaneous report from a contactable consumer or other non-health care professional (patient).   A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection; Batch/Lot Number: Not reported), via an unspecified route of administration on 09Mar2021 as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On 16Mar20211 week later, she was diagnosed with COVID-19. The patient underwent lab tests and procedures which included SARS-COV-2 antibody test positive: positive on 16Mar2021. The patient received monoclonal antibodies as a treatment on 17Mar2021. She was advised to wait 90 days before any further vaccination. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
I?m not sure if it was related but a week after the vaccine, I developed bloat and loose stools that OTC meds didn?t help.  After 2 weeks with no relief, I contacted my PCP for upper abdominal pain (2 inches above my belly button).  I was given cipro for 1 week.  After diagnostic testing found diverticulosis, I started 10 days of flagyl.  The pain was gone after the cipro, stools returned to normal and no issues since.
more intense; Left mandibular lymph node under my jaw became very swollen; lymph node hurting; Very tender for a couple of days; This spontaneous case was reported by a consumer and describes the occurrence of LYMPH NODE PAIN (Very tender for a couple of days), CONDITION AGGRAVATED (more intense), LYMPHADENOPATHY (Left mandibular lymph node under my jaw became very swollen) and LYMPH NODE PAIN (lymph node hurting) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 011L20A) for COVID-19 vaccination.     The patient's past medical history included Irritable bowel syndrome and GERD. Concurrent medical conditions included Arthritis. Concomitant products included IBUPROFEN (MOTRIN [IBUPROFEN]), MELOXICAM, OXYCODONE HYDROCHLORIDE, OXYCODONE TEREPHTHALATE, PARACETAMOL (PERCOCET [OXYCODONE HYDROCHLORIDE;OXYCODONE TEREPHTHALATE;PARACETAMOL]), ACETYLSALICYLIC ACID (BABY ASPIRIN), VITAMIN C [ASCORBIC ACID], ZINC and VITAMIN D NOS for an unknown indication.   On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced CONDITION AGGRAVATED (more intense). In April 2021, the patient experienced LYMPH NODE PAIN (Very tender for a couple of days), LYMPHADENOPATHY (Left mandibular lymph node under my jaw became very swollen) and LYMPH NODE PAIN (lymph node hurting). At the time of the report, LYMPH NODE PAIN (Very tender for a couple of days) was resolving, CONDITION AGGRAVATED (more intense) outcome was unknown and LYMPHADENOPATHY (Left mandibular lymph node under my jaw became very swollen) and LYMPH NODE PAIN (lymph node hurting) had not resolved.            No treatment information was provided.
caregiver called pharmacy 8-1-2019 and indicated pt had redness and irritation at injection site and pt had vomiting. indicated that  vomiting stoped. indicated to apply ice pack for redness & irritation and take nsaid and call dr tomorrow. also rph will contact dr tomorrow
Patient presented to covid vaccine clinic. Pt received vaccine without complication. About 5 minutes after vaccination, patient came to front of room saying he felt like he was going to pass out and needed to lay down. Placed patient in  Reclining chair and elevated feet. Patient pale, but alert. 1 minute later patient became lethargic. Within seconds, breathing became labored and patient unarousable. RPH alerted urgent care while I tended to patient. Performed sternal rub and patient became alert. He was able to state his name, where he was. Pupils reactive, tracking well. Patient stated he always passes out from needles. Patient drank apple juice and remained alert. Urgent care team arrived to assess patient. VSS. After UC determine he was stable, I continued to monitor patient for an additional 30 minutes. He remained alert, awake, without distress. Patient tolerated apple juice. After 40 minutes, patient felt comfortable leaving. He walked out of building in stable condition.
c/o tingling and numbness down length of left arm (site of covid vaccine) extending to finger tips - per physicians consideration: patient should continue to watch or any signs of swelling, redness, and/or soreness. Tingling/numbness possibly due to hitting a nerve.
I had rear end pain started March 20 in the morning, it gets worse and worse till 3/23 that I can not tolerate and had to call clinic to make appointment. They got me in on March 25 (Thursday). Dr inspected and told me it's thrombus that caused huge pain. They did the surgery right away, removed thrombus. I never had blood clots problem and I was healthy, which my blood test result can prove. Thrombus generated 12 days after my J&J vaccine shot, I am reporting this side effect. You may find all my medical record from Doctor's office.
Late second dose/ second dose not administered at time of call; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 84-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 19th September 2019 with batch number 9AB33).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The patient received 1st dose of Shingrix. In January 2020, the reporter called the patient back to administer the second dose, but she refused to get 2nd dose of Shingrix. The patient never went back to receive the second dose, which led to incomplete course of vaccination. No further details about adverse events were reported at the time of reporting.  The reporter consented to follow up by phone. The VAERS details reported for 1st dose of Shingrix.
Positive test 09Aug2022; Positive test 09Aug2022; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 49-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 05Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 48 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: DEXAMETHASONE, start date: 09Aug2022, stop date: 15Aug2022. Past drug history included: Morphine, reaction(s): "Allergy". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 09Aug2022, outcome "not recovered" and all described as "Positive test 09Aug2022". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (09Aug2022) Positive, notes: Positive test 09Aug2022; (17Aug2022) Negative, notes: Negative test 17Aug2022; (20Aug2022) Positive, notes: Positive Test again 20Aug2022 with symptoms returning runny nose, cough. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: COVID Rebound after treatment. Positive test 09Aug2022. Treatment with Paxlovid starting 09Aug2022. Negative test 17Aug2022. Continued tingling, numbness in the body and significant fatigue. Positive Test again 20Aug2022 with symptoms returning runny nose, cough. Body aches continue.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.